The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
Abstract
The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Travis, W. D., Brambilla, E., Burke, A. P., Marx, A., & Nicholson, A. G. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000663 · Cited by 1,905
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E. L., & Piccirillo, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4859 · Cited by 1,845
Self-citationProphylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
Aupérin, A., Arriagada, R., Pignon, J.-P., Le Péchoux, C., Gregor, A., Stephens, R. J., Kristjansen, P. E. G., Johnson, B. E., Ueoka, H., Wagner, H., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410703 · Cited by 1,718
WHO classification of tumours of the lung, pleura, thymus and heart
Travis, W. D. (2015) · International Agency for Research on Cancer eBooks · Cited by 1,664
Turrisi, A. T., Kim, K., Blum, R., Sause, W. T., Livingston, R. B., Komaki, R., Wagner, H., Aisner, S., & Johnson, D. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400403 · Cited by 1,506
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
Pignon, J.-P., Arriagada, R., Ihde, D. C., Johnson, D. H., Perry, M. C., Souhami, R. L., Brodin, O., Joss, R. A., Kies, M. S., Lebeau, B., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212033272302 · Cited by 1,331
Antonia, S. J., López-Martin, J. A., Bendell, J., Ott, P. A., Taylor, M., Eder, J. P., Jäger, D., Pietanza, M. C., Le, D. T., de Braud, F., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30098-5 · Cited by 1,244
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
Slotman, B., Faivre-Finn, C., Kramer, G., Rankin, E., Snee, M., Hatton, M., Postmus, P., Collette, L., Musat, E., & Senan, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071780 · Cited by 1,133
von Pawel, J., Schiller, J. H., Shepherd, F. A., Fields, S. Z., Kleisbauer, J. P., Chrysson, N. G., Stewart, D. J., Clark, P. I., Palmer, M. C., Depierre, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.658 · Cited by 968
Hellmann, M. D., Callahan, M. K., Awad, M. M., Calvo, E., Ascierto, P. A., Atmaca, A., Rizvi, N. A., Hirsch, F. R., Selvaggi, G., Szustakowski, J. D., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.001 · Cited by 893
Warde, P., & Payne, D. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.6.890 · Cited by 816
O'Brien, M. E. R., Ciuleanu, T.-E., Tsekov, H., Shparyk, Y., Čučeviá, B., Juhasz, G., Thatcher, N., Ross, G. A., Dane, G. C., & Crofts, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5821 · Cited by 649
Faivre-Finn, C., Snee, M., Ashcroft, L., Appel, W., Barlesi, F., Bhatnagar, A., Bezjak, A., Cardenal, F., Fournel, P., Harden, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30318-2 · Cited by 592
Rudin, C. M., Pietanza, M. C., Bauer, T. M., Ready, N., Morgensztern, D., Glisson, B. S., Byers, L. A., Johnson, M. L., Burris, H. A., Robert, F., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30565-4 · Cited by 574
Self-citationProphylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission
Arriagada, R., Le Chevalier, T., Borie, F., Riviere, A., Chomy, P., Monnet, I., Tardivon, A., Viader, F., Tarayre, M., & Benhamou, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.183 · Cited by 565
Takahashi, T., Yamanaka, T., Seto, T., Harada, H., Nokihara, H., Saka, H., Nishio, M., Kaneda, H., Takayama, K., Ishimoto, O., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30230-9 · Cited by 549
Ott, P. A., Elez, E., Hiret, S., Kim, D.-W., Morosky, A., Saraf, S., Piperdi, B., & Mehnert, J. M. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.5069 · Cited by 521
Pesch, B., Kendzia, B., Gustavsson, P., Jöckel, K., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I. M., Brüske, I., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27339 · Cited by 509
Eckardt, J. R., von Pawel, J., Pujol, J.-L., Papai, Z., Quoix, E., Ardizzoni, A., Poulin, R., Preston, A. J., Dane, G., & Ross, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.3998 · Cited by 393
Advances in neuroendocrine lung tumors
Travis, W. D. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq380 · Cited by 327
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
Demedts, I. K., Vermaelen, K. Y., & van Meerbeeck, J. P. (2010) · European Respiratory Journal · doi:10.1183/09031936.00105009 · Cited by 216
Hellmann, M. D., Callahan, M. K., Awad, M. M., Calvo, E., Ascierto, P. A., Atmaca, A., Rizvi, N. A., Hirsch, F. R., Selvaggi, G., Szustakowski, J. D., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.011 · Cited by 196
A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer
Smit, E., Fokkema, E., Biesma, B., Groen, H., Snoek, W., & Postmus, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.54 · Cited by 190
Pietanza, M. C., Kadota, K., Huberman, K., Sima, C. S., Fiore, J. J., Sumner, D. K., Travis, W. D., Heguy, A., Ginsberg, M. S., Holodny, A. I., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2059 · Cited by 188
Owonikoko, T. K., Behera, M., Chen, Z., Bhimani, C., Curran, W. J., Khuri, F. R., & Ramalingam, S. S. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824c7f4b · Cited by 163
Goto, K., Ohe, Y., Shibata, T., Seto, T., Takahashi, T., Nakagawa, K., Tanaka, H., Takeda, K., Nishio, M., Mori, K., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30104-8 · Cited by 155
Activity of docetaxel (Taxotere) in small cell lung cancer
Smyth, J. F., Smith, I. E., Sessa, C., Schöffski, P., Wanders, J., Franklin, H., & Kaye, S. B. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90455-3 · Cited by 139
Davies, M. J., & Duffield, E. (2017) · ImmunoTargets and Therapy · doi:10.2147/itt.s141577 · Cited by 134
Masters, G. A., Declerck, L., Blanke, C. D., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.130 · Cited by 125
New Advances in the Second-Line Treatment of Small Cell Lung Cancer
Hurwitz, J. L., McCoy, F. P. G., Scullin, P., & Fennell, D. A. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0026 · Cited by 119
Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.
Yamamoto, N., Tsurutani, J., Yoshimura, N., Asai, G., Moriyama, A., Nakagawa, K., Kudoh, S., Takada, M., Minato, Y., & Fukuoka, M. (2006) · PubMed · Cited by 79
The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer
Horn, L., Reck, M., & Spigel, D. R. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0523 · Cited by 76
Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer
HOANG, T. N., Kim, K., Jaslowski, A. J., Koch, P., Beatty, P. A., McGovern, J., Quisumbing, M. B., Shapiro, G. R., Witte, R. S., & Schiller, J. H. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00273-3 · Cited by 65
Progress in the management of limited‐stage small cell lung cancer
Amini, A., Byers, L. A., Welsh, J. W., & Komaki, R. U. (2013) · Cancer · doi:10.1002/cncr.28505 · Cited by 60
Pathology of small cell carcinoma of the lung
Zakowski, M. F. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50015 · Cited by 60
Zauderer, M. G., Drilon, A., Kadota, K., Huberman, K. H., Sima, C. S., Bergagnini, I., Sumner, D. K., Travis, W. D., Heguy, A., Ginsberg, M. S., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.08.007 · Cited by 57
O 6 -Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?
Hiddinga, B. I., Pauwels, P., Janssens, A., & van Meerbeeck, J. P. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.07.014 · Cited by 28
Role of Immune Checkpoint Inhibitors in Small Cell Lung Cancer
Cooper, M. R., Alrajhi, A. M., & Durand, C. R. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000686 · Cited by 13
Cited by
Rudin, C. M., Brambilla, E., Faivre-Finn, C., & Sage, J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00235-0 · Cited by 1,570
Li, M., Lin, A., Luo, P., Shen, W., Xiao, D., Gou, L., Zhang, J., & Guo, L. (2020) · Aging · doi:10.18632/aging.102683 · Cited by 62
Metadata
- Authors
- Kalemkerian, G. P., Loo, B. W., Akerley, W., Attia, A., Bassetti, M., Boumber, Y., Decker, R., Dobelbower, M. C., Dowlati, A., Downey, R. J., Florsheim, C., Ganti, A. K. P., Grecula, J. C., Gubens, M. A., Hann, C. L., Hayman, J. A., Heist, R. S., Koczywas, M., Merritt, R. E., Mohindra, N., Molina, J., Moran, C. A., Morgensztern, D., Pokharel, S., Portnoy, D. C., Rhodes, D., Rusthoven, C., Sands, J., Santana-Davila, R., Williams, C. C., Hoffmann, K. G., & Hughes, M.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2018-10
- Volume
- 16
- Issue
- 10
- Pages
- 1171-1182
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2906783051
- Cited by
- 288
- References
- 39
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.